Accessibility Menu
 
Cardax logo

Cardax

(OTC) CDXI

Current Price$0.00
Market CapN/A
Since IPO (2014)-100%
5 Year-100%
1 Year+0%
1 Month-99%

Cardax Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$500.71K

Net Income (TTM)

$7.68M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

73.43 (High)

Price

$0.00

Volume

125

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

CDXI News

No articles available.

CDXI: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cardax

Industry

Pharmaceuticals

Headquarters

Honolulu, HI 96822, US

CDXI Financials

Key Financial Metrics (TTM)

Gross Margin

64%

Operating Margin

-6%

Net Income Margin

-9%

Return on Equity

0%

Return on Capital

34%

Return on Assets

-4%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$0.00

Shares Outstanding

802.50K

Volume

125

Short Interest

0.00%

Avg. Volume

21.75

Financials (TTM)

Gross Profit

$342.82K

Operating Income

$3.06M

EBITDA

$2.64M

Operating Cash Flow

$1.79M

Capital Expenditure

$14.61K

Free Cash Flow

$1.81M

Cash & ST Invst.

$19.18K

Total Debt

$4.78M

Cardax Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q1 2021YOY CHG

Revenue

$104.57K

-26.8%

Gross Profit

$66.20K

-17.1%

Gross Margin

63.30%

N/A

Market Cap

$0.00

N/A

Market Cap/Employee

N/A

N/A

Employees

10

N/A

Net Income

$1.82M

-25.5%

EBITDA

$935.51K

-71.3%

Quarterly Fundamentals

Name
Q1 2021YOY CHG

Net Cash

$5.34M

-86.3%

Accounts Receivable

$36.75K

-64.5%

Inventory

$962.86K

-13.8%

Long Term Debt

$211.36K

-78.9%

Short Term Debt

$5.18M

+170.5%

Return on Assets

-3.55%

N/A

Return on Invested Capital

33.56%

N/A

Free Cash Flow

$337.93K

+41.5%

Operating Cash Flow

$337.11K

+40.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MODCModern Technology Corp.
$0.00+0.00%
NBRVFNabriva Therapeutics plc
$0.00+0.00%
ELOXEloxx Pharmaceuticals, Inc.
$0.14+40.00%
NEXINexImmune, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.03-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.77+0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.15-0.06%
QQQInvesco QQQ Trust
$581.75-0.02%

Questions About CDXI

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.